Strata Critical Medical, Inc.

Strata Critical Medical, Inc.

SRTAW
Strata Critical Medical, Inc.US flagNASDAQ Global Market
0.00
USD
+0.00
- -
42,455.00Market Cap
Strata Critical Medical, Inc.
SRTAW
(NASDAQ Global Market)

Recent

price

0.00

P/E

ratio

- -

div

yld

- -

ROIC.AI

2019
2020
2021
2021
2022
2023
2024
2025
TTM
FRC
- -
- -
- -
- -
- -
- -
- -
- -
- -
Revenue per Share
- -
- -
- -
- -
- -
- -
- -
- -
- -
Basic EPS, GAAP
- -
- -
- -
- -
- -
- -
- -
- -
- -
Free Cash Flow per Basic Share
- -
- -
- -
- -
- -
- -
- -
- -
- -
Dividend per Share
- -
- -
- -
- -
- -
- -
- -
- -
- -
Book Value per Share
- -
- -
- -
- -
- -
- -
- -
- -
- -
Tangible Book Value per Share
- -
- -
- -
- -
- -
- -
- -
- -
- -
Basic Weighted Avg Shares
31
23
51
- -
146
225
147
197
254
Sales/Revenue/Turnover
-37
-44.21
-47.68
- -
-36.63
-30.25
-15.34
-11.34
-7.85
Operating Margin (%)
- -
1
1
- -
6
7
6
8
10
Depreciation Expense
-11
-10
-40
- -
-27
-56
-27
41
47
Net Income, GAAP
- -
- -
- -
- -
- -
- -
- -
- -
- -
Effective Tax Rate (%)
-34.74
-43.36
-79.27
- -
-18.66
-24.9
-18.6
20.97
18.48
Profit Margin (%)
- -
8
305
282
192
171
138
106
103
Working Capital
- -
- -
- -
- -
15
20
2
3
3
LT Debt
- -
11
291
291
274
234
222
279
286
Total Equity
- -
- -
- -
- -
- -
- -
- -
- -
- -
Return on Invested Capital (%)
- -
- -
- -
- -
- -
- -
- -
- -
- -
Return on Capital (%)
- -
- -
- -
- -
- -
- -
- -
- -
- -
Return on Common Equity (%)

Capital Structure

FRC

in mil. unless spec.
Sep'25
Dec'25
Mar'26
ST Debt
1
1
1
LT Borrowings
- -
- -
- -
LT Finance Leases
3
3
3
Preferred Equity and Hybrid Capital
- -
- -
- -
Shares Outstanding
86
87
87
Market Capitalization
- -
- -
- -

Working Capital

FRC

in mil. unless spec.
Sep'25
Dec'25
Mar'26
Total Current Assets
122
126
124
Cash, Cash Equivalents & STI
76
61
59
Accounts Receivable, Net
38
40
40
Inventories
- -
- -
- -
Total Current Liabilities
28
20
21
Payables & Accruals
27
19
20
ST Debt
1
1
1
Deferred Revenue
- -
- -
- -

Growth Rates

FRC

in mil. unless spec.

(avg. rate of change)

10 years
5 years
1 year
Total Equity
- -
0.02%
25.74%
Free Cash Flow
- -
- -
75.28%
Net Income, GAAP
- -
- -
-251.42%
Sales/Revenue/Turnover
- -
- -
34.28%
Total Cash Common Dividend
- -
- -
- -

Quarterly Revenue

FRC

in mil. unless spec.

Year

Q1
Q2
Q3
Q4
FY
2024
52
68
36
54
147
2025
36
71
49
67
197
2026
67
- -
- -
- -
- -

Quarterly Earnings Per Share

FRC

in mil. unless spec.

Year

Q1
Q2
Q3
Q4
FY
2024
- -
- -
- -
- -
- -
2025
- -
- -
- -
- -
- -
2026
- -
- -
- -
- -
- -

Quarterly Dividends Per Share

FRC

in mil. unless spec.

Year

Q1
Q2
Q3
Q4
FY
2024
- -
- -
- -
- -
- -
2025
- -
- -
- -
- -
- -
2026
- -
- -
- -
- -
- -
Business
Strata Critical Medical, Inc. (Ticker: SRTAW) develops and commercializes innovative medical devices focused on critical care solutions, including advanced airway management systems, emergency ventilation technologies, and portable diagnostic tools for respiratory distress; the company offers proprietary StrataVent disposable ventilators, StrataAir non-invasive oxygen delivery masks, and integrated monitoring software platforms for real-time patient data analysis in hospital and field settings. Founded in 2018 and headquartered in Irvine, California, Strata operates primarily in the United States with expanding distribution in North America and select European markets, targeting hospitals, emergency medical services, and military applications within the medical devices segment of the healthcare industry. In the past year, the company completed a significant Series B funding round exceeding $25 million led by healthcare-focused venture firms, enabling accelerated production scaling and FDA clearance for its next-generation StrataPulse portable ventilator; additionally, Strata announced a strategic partnership with a major defense contractor in Q3 2025 for customized critical care kits and acquired a small biomedical firm specializing in sensor technology to enhance its product ecosystem.

Company News

APIChatGPT
  • Strata Critical Medical Announces Expiration of Warrants

  • Strata Critical Medical, Inc. (SRTA) Q1 2026 Earnings Call Transcript